Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, today presented on its proprietary ...

Translating regenerative medicine from lab research to large-scale clinical and commercial production requires robust, scalable, and tightly controlled ...

Medical device manufacturing is a high-stakes game where efficiency meets precision. With tight regulations, complex designs, and a need for speed, how do companies stay ahead without cutting corners?

The Advanced Research Projects Agency for Health ( ARPA-H) awarded BioCurie up to $9.3 million to accelerate the development of scalable, data-driven genomic medicine production.

The Forum on Regenerative Medicine hosted a public workshop to examine and discuss challenges, opportunities, and best practices associated with defining and measuring the quality of cell and tissue ...

Process development is the exercise of creating new and improved manufacturing methods, optimizing them in terms of time and financial efficiency while maintaining regulatory compliance and product ...

Modern conveyance systems help medtech manufacturers achieve flexibility, compliance, and integration in smart factories.

Technological innovations throughout the past several decades have transformed the pharmaceutical manufacturing process from traditional batch production to ...

How one medical device manufacturer achieved a 65x faster process, $800,000 in material savings, and reduced reliance on ...

HCW Biologics Inc. (NASDAQ:HCWB) announced new research published in Science Advances indicating that its compound HCW9206 may improve the production of CAR-T cell therapies. The study was carried out ...

Advanced technologies can help personalized medicine firms minimize their environmental impact, but only if used as part of a strategic plan that takes all aspects of production, storage, and ...